OPENING OF BANKRUPTCY

BECARV

Export PDF
Financial year 2026 · closed on 31/03/2026
Net result
-2,7 M €
-80.5% YoY
Gross margin
110,7 k €
+124.4% YoY
Equity
-2,6 M €
-709.5% YoY
Workforce
8,0 ETP
-22.3% YoY

Company — Opening of bankruptcy.

Strike-off: 03 juillet 2026

What does BECARV do?

BECARV is a Public limited company incorporated in 2011. Its main activity is: Engineering activities and related technical consultancy. Its registered office is in Liège. It employs on average 8,0 ETP workers (FTE).

Legal situation
● Opening of bankruptcy
BCE/KBO no. / VAT
BE 0840.777.885
Incorporation
03/11/2011
Legal form
Public limited company
Registered office
Boulevard de Patience et Beaujonc 3 box 26
4000 Liège · WallonieSee on map
Contributed capital
514 752,76 €
Latest accounts
31/03/2026
Average workforce
8,0 ETP
Activities (NACE)
71121Engineering activities and related technical consultancy· main71121Engineering activities and related technical consultancy
Joint committees (3)
  • 100
  • 11101
  • 209
Signals
Healthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 15 financial years

202620252024202320222021202020192018201720162015201420132012
Income statement
Gross margin110,7 k €-453,3 k €823 k €773,2 k €958,8 k €385,1 k €323,9 k €433,1 k €468,9 k €389,5 k €281,6 k €-33,3 k €30,5 k €54,1 k €38,9 k €
EBITDA-2,4 M €-1,2 M €63,8 k €159,1 k €350,9 k €90,9 k €-181,4 k €-22,3 k €26 k €157,3 k €135,2 k €-65,1 k €24,1 k €48,4 k €38,9 k €
Operating result-2,8 M €-1,5 M €-164,3 k €24,2 k €229 k €-37,7 k €-341,5 k €-170,4 k €-95,4 k €69,6 k €69,8 k €-97,1 k €16,7 k €40,7 k €38,2 k €
Net result-2,7 M €-1,5 M €-115,3 k €17,4 k €174,9 k €-78,1 k €-386,7 k €-204,3 k €-128,5 k €34,1 k €42,3 k €-108 k €11 k €24,4 k €25,3 k €
Balance sheet
Equity-2,6 M €419,2 k €1,1 M €1,3 M €650,4 k €475,5 k €-496,3 k €-109,6 k €94,7 k €223,2 k €189,1 k €46,8 k €41,4 k €18 k €16,3 k €
Total assets307,4 k €2,5 M €3,3 M €2,9 M €1,7 M €1,8 M €764,8 k €1,3 M €1,1 M €949,7 k €820,2 k €416,6 k €87,5 k €111,1 k €64,4 k €
Cash29 k €145,3 k €1,1 M €657,1 k €619,5 k €993,5 k €114 k €211,9 k €198,7 k €121,6 k €228,6 k €246,6 k €24,2 k €22,9 k €11,9 k €
Debts2,7 M €2,1 M €2,2 M €1,4 M €1,1 M €1,3 M €1,3 M €1,4 M €992,6 k €716,2 k €621,2 k €349,6 k €27 k €74,5 k €43,1 k €
Other
Workforce8,0 ETP10,3 ETP10,6 ETP10,7 ETP8,8 ETP5,2 ETP7,8 ETP7,0 ETP7,5 ETP4,8 ETP2,0 ETP1,0 ETP–––
Governance

Board of directors

Seen on filing of 31/03/2026 · 5 active · 12 ended

Active mandates

Eric Jeanty

Chairman of the board of directors · since 31 mars 2024 · until 03 juillet 2027

Active
NOSHAQ PARTNERS

Director · since 29 janvier 2022 · until 03 juillet 2027 · 0808.219.836

Represented by Patrick STRAGIER

Active
Jean STEPHENNE

Director · since 31 mars 2021 · until 03 juillet 2027

Active
JMichael

Managing director · since 31 mars 2021 · until 03 juillet 2027 · 0764.333.670

Represented by Michael Jeanty

Active
ORSA ADMIN

Director · since 31 mars 2021 · until 03 juillet 2027 · 0890.073.384

Represented by DETRIXHE PIERRE

Active

Ended mandates

Eric JEANTY

Chairman of the board of directors · since 31 mars 2021 · until 03 juillet 2027

Ended
JMichael

Director · since 31 mars 2021 · until 03 juillet 2027 · 0764.333.670

Represented by JEANTY MICHAEL

Ended
NOSHAQ

Director · since 31 mars 2021 · until 03 juillet 2027 · 0426.624.509

Represented by Eric BRANDT

Ended
ORSA ADMIN

Director · since 31 mars 2021 · until 03 juillet 2027 · 0890.073.384

Represented by Pierre DETRIXHE

Ended
At this address

Other companies at this address

CompanyCBE no.
Abscint● Active
0749.828.410
AMPACIMON● Active
0827.990.317
Amyl Therapeutics● Active
0758.775.372
BE.SPINE● Active
1013.110.857
CEFALY Technology● Active
0870.578.661
DERMAX● Active
0667.730.677
DIANOSIC● Active
1034.558.646
DW Cefaly Holding● Active
0725.837.241
EARTH ALIVE CLEAN TECHNOLOGIES BELGIUM● Active
1023.778.481
EXO Biologics● Active
0732.982.379
ExoXpert● Active
1003.807.666
Hirundo Biosciences● Active
0681.855.065
HolyFox Invest● Active
1010.693.181
Hyloris● Active
0669.738.676
Hyloris Developments● Active
0542.737.368
Hyloris Pharmaceuticals● Active
0674.494.151
Hyloris Therapeutics● Active
1025.029.385
LEGIAPARK● Active
0728.589.170
MAN & SCIENCE● Active
0837.403.770
ONCORADIOMICS● Active
0662.719.440
Annual accounts

Full financial information

202620252024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/04/202501/04/202401/04/202301/04/202201/04/202101/04/2020
Closing of the financial year31/03/202631/03/202531/03/202431/03/202331/03/202231/03/2021
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/06/202630/10/202522/10/202406/10/202326/09/202228/07/2021
General meeting18/06/202626/09/202530/09/202420/07/202302/07/202201/07/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

15 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/03/202618/06/202623/06/2026FrenchPDF
Abridged model31/03/202526/09/202530/10/2025FrenchPDF
Abridged model31/03/202430/09/202422/10/2024FrenchPDF
Abridged model31/03/202320/07/202306/10/2023FrenchPDF
Abridged model31/03/202202/07/202226/09/2022FrenchPDF
Abridged model31/03/202101/07/202128/07/2021FrenchPDF
Abridged model31/03/202029/09/202030/10/2020FrenchPDF
Abridged model31/03/201923/09/201901/10/2019FrenchPDF
Abridged model31/03/201807/07/201828/09/2018FrenchPDF
Abridged model31/03/201712/07/201722/07/2017FrenchPDF
Abridged model31/03/201620/07/201627/07/2016FrenchPDF
Abridged model31/03/201524/07/201531/07/2015FrenchPDF
Abridged model31/03/201405/07/201430/07/2014FrenchPDF
Abridged model31/03/201328/09/201323/10/2013FrenchPDF
Abridged model31/03/201201/07/201220/07/2012FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2026 · 5 active · 12 ended

Active mandates

Eric Jeanty

Chairman of the board of directors · since 31 mars 2024 · until 03 juillet 2027

Active
NOSHAQ PARTNERS

Director · since 29 janvier 2022 · until 03 juillet 2027 · 0808.219.836

Represented by Patrick STRAGIER

Active
Jean STEPHENNE

Director · since 31 mars 2021 · until 03 juillet 2027

Active
JMichael

Managing director · since 31 mars 2021 · until 03 juillet 2027 · 0764.333.670

Represented by Michael Jeanty

Active
ORSA ADMIN

Director · since 31 mars 2021 · until 03 juillet 2027 · 0890.073.384

Represented by DETRIXHE PIERRE

Active

Ended mandates

Eric JEANTY

Chairman of the board of directors · since 31 mars 2021 · until 03 juillet 2027

Ended
JMichael

Director · since 31 mars 2021 · until 03 juillet 2027 · 0764.333.670

Represented by JEANTY MICHAEL

Ended
NOSHAQ

Director · since 31 mars 2021 · until 03 juillet 2027 · 0426.624.509

Represented by Eric BRANDT

Ended
ORSA ADMIN

Director · since 31 mars 2021 · until 03 juillet 2027 · 0890.073.384

Represented by Pierre DETRIXHE

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates04/12/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates29/07/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates27/11/2024
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates03/01/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates24/11/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates02/06/2021
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates22/04/2021
    CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates27/11/2020
    DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2026
    Annual accounts 2026-2,7 M €↓
  2. 2025
    Annual accounts 2025-1,5 M €↓
  3. 2024
    Annual accounts 2024-115,3 k €↓
  4. 2023
    Annual accounts 202317,4 k €↓
  5. 2022
    Annual accounts 2022174,9 k €↑
  6. 2021
    Annual accounts 2021-78,1 k €↑
  7. 2020
    Annual accounts 2020-386,7 k €↓
  8. 2019
    Annual accounts 2019-204,3 k €↓
  9. 2018
    Annual accounts 2018-128,5 k €↓
  10. 2017
    Annual accounts 201734,1 k €↓
  11. 2016
    Annual accounts 201642,3 k €↑
  12. 2015
    Annual accounts 2015-108 k €↓
  13. 2014
    Annual accounts 201411 k €↓
  14. 2013
    Annual accounts 201324,4 k €↓
  15. 2012
    Annual accounts 201225,3 k €
  16. 03/11/2011
    IncorporationPublic limited company